Candriam SCA’s Achaogen Inc AKAO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-127,555
Closed -$1.1M 860
2018
Q2
$1.1M Sell
127,555
-95,000
-43% -$1.16M 0.02% 591
2018
Q1
$2.88M Buy
222,555
+50,000
+29% +$567K 0.05% 400
2017
Q4
$1.85M Sell
172,555
-10,000
-5% -$126K 0.03% 471
2017
Q3
$2.91M Sell
182,555
-18,000
-9% -$343K 0.05% 375
2017
Q2
$4.36M Buy
200,555
+120,000
+149% +$2.74M 0.08% 291
2017
Q1
$2.03M Sell
80,555
-9,445
-10% -$194K 0.04% 449
2016
Q4
$1.17M Buy
+90,000
New +$617K 0.03% 487

Other funds holding AKAO

Candriam SCA's AKAO Position: Q3 2018 in Review

Candriam SCA sold out of Achaogen Inc (AKAO) in Q3 2018, closing a stake of 127,555 shares — an estimated $1.1M sold.

Candriam SCA first reported a position in AKAO in Q4 2016 and held it in 7 quarters. The position peaked at $4.36M in Q2 2017. 92 funds tracked by Wall St. Rank hold AKAO as of Q3 2018.

  • Candriam SCA reported no remaining Achaogen Inc position as of Q3 2018 after selling out during the quarter.
  • Candriam SCA sold 127,555 Achaogen Inc shares in Q3 2018, an estimated $1.1M.
  • Candriam SCA first reported a position in Achaogen Inc in Q4 2016 and held it in 7 quarters.
  • Candriam SCA's Achaogen Inc position peaked at $4.36M in Q2 2017.
  • 92 funds tracked by Wall St. Rank held Achaogen Inc as of Q3 2018.

Based on Candriam SCA's 13F filing for Q3 2018, filed 7 Nov 2018.